No Data
No Data
Verastem Oncology Receives FDA Clearance for Investigational New Drug Application for Cancer Treatment
Verastem Announces U.S. IND Clearance of VS-7375
Express News | Verastem Inc - Phase 1/2a Trial in U.S. to Start Mid-2025
Express News | Verastem Oncology Announces U.S. Ind Clearance of Vs-7375, Oral Kras G12D (on/off) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors
9 Health Care Stocks With Whale Alerts In Today's Session
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday